Compare Oatly Group AB - ADR (OTLY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oatly Group AB - ADR vs Relay Therapeutics Inc. Common Stock — how do they compare? Oatly Group AB - ADR trades at $11.93 (market cap $330.93M), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 11.9× Oatly Group AB - ADR's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oatly Group AB - ADR for 18 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| OTLY | RLAY | |
|---|---|---|
Market Cap | $330.93M | $3.94B |
Volume | 44,023 | 3,432,928 |
Sector | Consumer Staples | Health |
52-Week High | $15.91 | $20.75 |
52-Week Low | $8.03 | $6.03 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $835.34M | $3.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oatly (OTLY) trades at $10.38, down 1.24% today, with a mixed technical picture showing bearish moving averages but oversold RSI levels. The company continues to report revenue growth ($862M in 2025) but remains unprofitable with a -17.72% net margin. Recent Q2 2026 results showed a revenue beat and improved guidance, driving positive sentiment. Analyst consensus is divided with a $12.28 price target, while cash flow trends show gradual operational improvement despite negative net income.
The outlook remains challenging as Oatly works toward profitability amid high debt levels and negative cash flow. Investment opportunity exists if margin improvements continue and the company achieves positive EBITDA. Key risks include execution on cost controls, competitive pressures in plant-based beverages, and the sustainability of recent revenue growth momentum in a challenging consumer environment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
